Consumer Goods » Food, Beverages & Tobacco | Eastgate Biotech Corp.

Eastgate Biotech Corp. | Balance Sheet

Fiscal year is January-December. All values USD Thousands.
2012
2013
2014
2015
2016
Cash & Short Term Investments
100.00
0.50
286.50
19.20
-
Total Accounts Receivable
-
-
53.20
79.70
-
Other Current Assets
4.50
-
-
14.60
-
Total Current Assets
104.50
0.50
339.70
113.50
-
Net Property, Plant & Equipment
-
71.30
143.20
184.40
-
Total Assets
104.50
71.80
482.90
297.90
-
ST Debt & Current Portion LT Debt
449.10
922.50
1,006.40
1,316.70
1,676.40
Accounts Payable
229.30
421.40
-
361.10
279.70
Other Current Liabilities
35.20
1,055.00
874.80
1,050.80
2,622.00
Total Current Liabilities
713.50
2,398.90
1,881.20
2,728.60
4,578.00
Long-Term Debt
-
-
-
50.40
40.00
Total Liabilities
713.50
2,398.90
1,881.20
2,779.00
4,618.10
Common Equity (Total)
609.00
2,327.20
1,398.30
2,481.10
4,618.10
Total Shareholders' Equity
609.00
2,327.20
1,398.30
2,481.10
4,618.10
Total Equity
609.00
2,327.20
1,398.30
2,481.10
4,618.10
Liabilities & Shareholders' Equity
104.50
71.80
482.90
297.90
-

About Eastgate Biotech

View Profile
Address
2203-65 Harbour Square
Toronto Ontario M5J 2L4
Canada
Employees -
Website http://www.eastgatebiotech.com
Updated 07/08/2019
Eastgate Biotech Corp. engages in the development of novel formulations of natural compounds and pharmaceutical products. It intends to accomplish by developing its proprietary self-emulsifying drug delivery systems, predominantly forming nanoemulsions. The company was founded on September 8, 1999 and is headquartered in Toronto, ON.